Etrasimod is named as a drug or biological intervention in 5 clinical trials in our USA, UK and India trial registers, 3 of which are recruiting. The lead sponsor is Pfizer. Registered phases: Phase 2, Observational and Phase 3. Conditions studied include Colitis, Ulcerative; Ulcerative Colitis.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT05287126 | A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis (ClinicalTrials.gov ↗) Ulcerative Colitis |
Phase 2 | Recruiting |
| NCT07470879 | A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis (ClinicalTrials.gov ↗) Colitis, Ulcerative |
Phase 2 | Recruiting |
| NCT06398626 | An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis (ClinicalTrials.gov ↗) Colitis, Ulcerative |
Observational | Recruiting |
| NCT03950232 | An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis (ClinicalTrials.gov ↗) Ulcerative Colitis |
Phase 3 | Active, closed |
| NCT06294925 | A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis (ClinicalTrials.gov ↗) Colitis, Ulcerative |
Observational | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Colitis, Ulcerative | 3 |
| Ulcerative Colitis | 2 |
| Lead sponsor | Trials |
|---|---|
| Pfizer | 5 |
| Register | Etrasimod trials |
|---|---|
| Clinical trials in USA | 4 |
| Clinical trials in UK | 3 |
| Clinical trials in India | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Etrasimod works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Etrasimod (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.